Argentina begins doling out free 'Viagra'

Argentina has begun distributing a free state-produced version of the erection-boosting drug Viagra for the first time, in a move intended to curb its misuse, health authorities announced Thursday.

They said 200,000 doses of sildenafil, better known under the Viagra brand name, is to be distributed free of charge through the public health network of the province of Santa Fe.

The drug is being produced in Santa Fe by the state-owned LIFSE, which plans to eventually distributed it nationally.

Sildenafil is a hugely popular vasodilator that is used to treat erectile dysfunction in men.

"The most famous medication in the world for improving the quality of life—even though no-one is going to lose their life over it—is the first to be made by the state in Argentina," said Guillermo Cleti, a LIFSE director.

"It's not only to attend to erectile dysfunction in men who need it, but also to avoid the abuse or bad use of the drug and to warn the population about its correct use," he said.

Related Stories

Canada high court voids Pfizer's Viagra patent

date Nov 08, 2012

Canada's top court on Thursday stripped Pfizer of its patent for Viagra, saying the pharmaceutical giant failed in the patent to identify the active compound in the drug.

Bangladesh doctors urge Viagra production halt

date Sep 26, 2012

Bangladeshi doctors Wednesday asked the government to halt permits for Viagra to be mass produced for the domestic market, fearing it could lead to the anti-impotence drug becoming available over the counter.

Viagra sales don't meet expectations

date May 20, 2007

While sales of erectile dysfunction drugs like Viagra have been steady since their release, their popularity has not met expectations, the Miami Herald said.

Recommended for you

J&J seeks bioethics advice on compassionate use of drugs

date 30 minutes ago

Dying patients sometimes seek emergency access to experimental medicines, desperate for a last-chance treatment even if there's little proof it could help. Now drug giant Johnson & Johnson is taking an unusual ...

GlaxoSmithKline opts to hold on to HIV business

date 19 hours ago

British-based drugmaker GlaxoSmithKline opted Wednesday to keep its stake in its stand-alone HIV business as it set out its strategy following a big deal with Switzerland's Novartis.

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.